Because the peptide works specifically on fat tissue without affecting other systems, protocols can be designed purely around fat metabolism optimization without concerns about managing glucose, IGF-1, or growth-related effects
The shift towards H 2 S-producing pathways may be driven by down-regulation of the aerobic oxidative degradation of cysteine to taurine, mediated by cysteine dioxygenase, as evidenced by the lower taurine/cysteine ratio in arterial cord blood, not only in severe IPTB cases, irrespective of treatment, but in NAC-treated moderate IPTB cases as well
both are, in fact, banned in sport
* Meets US Pharmacopeia Standard
Book your appointment today at Intra-V in The Woodlands or Katy, TX and give your body the antioxidant support it needs